Adma Biologics (ADMA)

$17.52 +0.02 (0.11%)
Market Cap 4.12B
Revenue (ttm) 426.45M
Net Income (ttm) 197.67M
EPS (ttm) N/A
PE Ratio 28.83
Forward PE 20.01
Profit Margin 46.35%
Debt to Equity Ratio 0.16
Volume 1,525,800
Avg Vol 2,488,326
Day's Range N/A - N/A
Shares Out 238.00M
Stochastic %K 73%
Beta 0.47
Analysts Strong Sell
Price Target $30.00

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute e...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
the_shalashaska
the_shalashaska Feb. 3 at 5:58 PM
$ADMA thank god I still hold this beast, cannot be disrupted by AI lol
0 · Reply
Smartynow
Smartynow Feb. 2 at 7:22 PM
$ADMA
0 · Reply
ncost1
ncost1 Jan. 31 at 6:52 PM
$ADMA p/s ratio is 6.4. Industry average is 10-11. Undervalued here. I know longs are already overweight myself included but this price is simply too cheap to sit back and watch.
1 · Reply
BabetteCH
BabetteCH Jan. 30 at 10:08 PM
$ADMA sBLA PED is close …
0 · Reply
BabetteCH
BabetteCH Jan. 30 at 6:52 PM
$ADMA dow up, ADMA down! As usual…
0 · Reply
BabetteCH
BabetteCH Jan. 30 at 6:22 PM
$ADMA now back to 16.50 😂🤣
1 · Reply
jerzbondon
jerzbondon Jan. 30 at 3:59 PM
$ADMA I guess we need more down market days 🤔
0 · Reply
oaksapollo
oaksapollo Jan. 30 at 3:40 PM
$ADMA my one bright spot on an otherwise dark and stormy day.
0 · Reply
baston
baston Jan. 30 at 3:33 PM
$ADMA Up on solid volume. On red day... News coming maybe?
0 · Reply
ncost1
ncost1 Jan. 30 at 3:32 PM
$ADMA my 4k buy from this week is looking nice.
0 · Reply
Latest News on ADMA
ADMA Biologics: Business Update And My Price Target

Jan 14, 2026, 9:17 AM EST - 20 days ago

ADMA Biologics: Business Update And My Price Target

ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 4:16 PM EST - 22 days ago

ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

Jan 12, 2026, 8:00 AM EST - 22 days ago

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

Jan 5, 2026, 7:00 AM EST - 4 weeks ago

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

ADMA Biologics: Why The Dip To $16 Resets The Buy Case

Nov 20, 2025, 4:35 PM EST - 2 months ago

ADMA Biologics: Why The Dip To $16 Resets The Buy Case

ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 3:31 AM EST - 3 months ago

ADMA Biologics, Inc. (ADMA) Q3 2025 Earnings Call Transcript

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

Nov 5, 2025, 4:05 PM EST - 3 months ago

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 29, 2025, 7:00 AM EDT - 3 months ago

ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025

3 Biotech Stocks I Am Accumulating

Oct 15, 2025, 2:30 PM EDT - 3 months ago

3 Biotech Stocks I Am Accumulating

HRMY INCY SNDX XBI

ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

Sep 3, 2025, 6:12 AM EDT - 5 months ago

ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

Aug 10, 2025, 9:15 AM EDT - 6 months ago

ADMA Biologics: Optionality With SG-001 And A Vertically Integrated IG Platform

ADMA Biologics: A Better Quarter Than Headline Numbers

Aug 8, 2025, 3:58 PM EDT - 6 months ago

ADMA Biologics: A Better Quarter Than Headline Numbers

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:14 PM EDT - 6 months ago

ADMA Biologics, Inc. (ADMA) Q2 2025 Earnings Call Transcript

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

Aug 6, 2025, 4:05 PM EDT - 6 months ago

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 30, 2025, 7:00 AM EDT - 6 months ago

ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

Jun 15, 2025, 4:11 AM EDT - 8 months ago

ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade)

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

May 9, 2025, 3:54 AM EDT - 9 months ago

ADMA Biologics: Ready For More Growth Despite Q1 Earnings Miss

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:05 PM EDT - 9 months ago

ADMA Biologics, Inc. (ADMA) Q1 2025 Earnings Call Transcript

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

May 7, 2025, 4:05 PM EDT - 9 months ago

ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 30, 2025, 7:00 AM EDT - 9 months ago

ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

Apr 28, 2025, 7:00 AM EDT - 10 months ago

ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process

ADMA Biologics Statement on Tariffs

Apr 7, 2025, 7:00 AM EDT - 10 months ago

ADMA Biologics Statement on Tariffs

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

Mar 21, 2025, 3:04 PM EDT - 11 months ago

ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

Mar 4, 2025, 1:50 PM EST - 1 year ago

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed 10-K and KPMG Evaluation of Controls

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 6:24 PM EST - 1 year ago

ADMA Biologics, Inc. (ADMA) Q4 2024 Earnings Call Transcript

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 3, 2025, 4:05 PM EST - 1 year ago

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

Feb 28, 2025, 7:00 AM EST - 1 year ago

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 25, 2025, 7:00 AM EST - 1 year ago

ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

Feb 6, 2025, 1:46 PM EST - 1 year ago

ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

Dec 20, 2024, 7:00 AM EST - 1 year ago

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

Dec 13, 2024, 5:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm

Dec 11, 2024, 6:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 9, 2024, 5:45 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Defrauding The Public And Affected Investors Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

Dec 7, 2024, 5:30 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm

Dec 5, 2024, 2:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm

Dec 3, 2024, 3:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Looked Into For Securities Fraud And Investors With Losses Are Invited To Assist The Schall Law Firm

ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV

Dec 2, 2024, 8:30 AM EST - 1 year ago

ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

Dec 1, 2024, 3:15 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Impacted Investors Are Invited To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Nov 29, 2024, 12:30 PM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Committing Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

Nov 26, 2024, 11:00 AM EST - 1 year ago

ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm

the_shalashaska
the_shalashaska Feb. 3 at 5:58 PM
$ADMA thank god I still hold this beast, cannot be disrupted by AI lol
0 · Reply
Smartynow
Smartynow Feb. 2 at 7:22 PM
$ADMA
0 · Reply
ncost1
ncost1 Jan. 31 at 6:52 PM
$ADMA p/s ratio is 6.4. Industry average is 10-11. Undervalued here. I know longs are already overweight myself included but this price is simply too cheap to sit back and watch.
1 · Reply
BabetteCH
BabetteCH Jan. 30 at 10:08 PM
$ADMA sBLA PED is close …
0 · Reply
BabetteCH
BabetteCH Jan. 30 at 6:52 PM
$ADMA dow up, ADMA down! As usual…
0 · Reply
BabetteCH
BabetteCH Jan. 30 at 6:22 PM
$ADMA now back to 16.50 😂🤣
1 · Reply
jerzbondon
jerzbondon Jan. 30 at 3:59 PM
$ADMA I guess we need more down market days 🤔
0 · Reply
oaksapollo
oaksapollo Jan. 30 at 3:40 PM
$ADMA my one bright spot on an otherwise dark and stormy day.
0 · Reply
baston
baston Jan. 30 at 3:33 PM
$ADMA Up on solid volume. On red day... News coming maybe?
0 · Reply
ncost1
ncost1 Jan. 30 at 3:32 PM
$ADMA my 4k buy from this week is looking nice.
0 · Reply
BabetteCH
BabetteCH Jan. 30 at 3:15 PM
$ADMA high volume! 🚀
0 · Reply
StockBraker
StockBraker Jan. 30 at 1:26 PM
$ADMA Grok summary of the upcoming ER in about a month. Overall, the Earnings report's tone on Asceniv demand, margin trajectory, and multi-year growth visibility will likely be the biggest drivers. Analysts maintain a consensus price target of ~$28–30 (implying 65–75% upside from late-January levels around $17), with a "Buy" rating, reflecting confidence in these levers. However, risks include any delays in yield scaling or competitive pressures in the plasma-derived products space.
1 · Reply
StockBraker
StockBraker Jan. 29 at 9:19 PM
$ADMA https://www.nasdaq.com/articles/adma-biologics-enters-oversold-territory-adma
0 · Reply
uhhhhhhhhhhh
uhhhhhhhhhhh Jan. 29 at 5:28 PM
$ADMA all it takes is that red market babeyyyy. Adma loves the countercurrent flow
1 · Reply
StockBraker
StockBraker Jan. 29 at 4:19 PM
$ADMA Patience people. Your reward will come in due course. DCA if you can or add to holdings even if you’re averaging up a bit. At $23 you will get 35% ROI from today’s price. Market is down overall and we’re up, so that’s a positive.
1 · Reply
gorwell
gorwell Jan. 29 at 12:49 PM
$ADMA i can't help but think if the last 12omths worth of macro rubbish hadn't left the normally untouchable CEO crowd scratching THEIR heads, we'd be 30-40$ by now.
0 · Reply
USMAgrad
USMAgrad Jan. 28 at 5:48 PM
$ADMA This may actually get taken under $16 by Friday… which, frankly, is nothing short of mind blowing. I still contend that anything under $18 is a bargain… anything in the $15’s to low $16’s is basically stealing
1 · Reply
BabetteCH
BabetteCH Jan. 28 at 4:52 PM
$ADMA btw: Adam’s Rule 10b5-1 trading plan finished by year-end 2025. The takeover window is now open… 😉
1 · Reply
hakoah
hakoah Jan. 28 at 3:54 PM
$ADMA I had 20,000 shares now down to 5,000. If this continues bye bye
1 · Reply
Tbonez
Tbonez Jan. 28 at 3:51 PM
$ADMA every damn day it bleeds some more
0 · Reply
BabetteCH
BabetteCH Jan. 28 at 3:49 PM
$ADMA what is wrong with this bs stock?!?
0 · Reply
ncost1
ncost1 Jan. 28 at 3:11 PM
$ADMA dead money until it’s not. The street needs to see actual numbers not guidance. When it moves we will move fast so you have to be patient. A few quarters of earnings will sent this to ath.
1 · Reply